Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 75.35 INR
Change Today 0.00 / 0.00%
Volume 0.0
BLP On Other Exchanges
Natl India
As of 7:05 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

bal pharma ltd (BLP) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/5/14 - 104.00
52 Week Low
03/27/15 - 49.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BAL PHARMA LTD (BLP)

Related News

No related news articles were found.

bal pharma ltd (BLP) Related Businessweek News

No Related Businessweek News Found

bal pharma ltd (BLP) Details

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (API) in India. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides a range of APIs for therapeutic areas, such as acne treatment, diuretic, anti-histamine, anti-inflammatory, anti-diabetic, sedative/hypnotic, anti-allergy, neuropathic pain, urinary incontinence, anti-convulsant, anti-diabetic, and insomnia, as well as offers various finished formulations. The company also offers ayurvedic products comprising ANARSHA for regularize bowl movement; ASHWAMED for sexual and general debility; AYURFINE and AYURFINE FORTE, which are anti-arthritics for osteoarthritis, rheumatoid arthritis, and spondylitis; AYURSULIN for managing diabetes; IMMUWIN, an immune building supplement; and LIPIVED for reducing cholesterol. In addition, it ayurvedic products consist of MENOLEAP capsules and syrup for menstrual disorders; PROLIFE, which provides life to ailing liver; BALPRO SYRUP for stable and synchronized liver functions; PROSTOWIN for benign prostatic hyperplasia; STONEX for expulsion of kidney stones; SUJIRNA for digestion; SUSWAS, an antallergic/antiasthamatic product; and BALVAC, a mild laxative. The company exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and other world markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Founded in 1987

bal pharma ltd (BLP) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 7.2M
Whole-Time Director, Chairman of Banking Tran...
Total Annual Compensation: 3.0M
Compensation as of Fiscal Year 2015.

bal pharma ltd (BLP) Key Developments

Bal Pharma Ventures into OTC Segment

Bal Pharma Ltd. has announced the launch of its maiden OTC (over the counter) product 'Eye Spa', in Bangalore market. This is first among the series of OTC products that the Company has lined up for launching in the market through its subsidiary i.e Lifezen Healthcare Pvt Ltd. 'Eye Spa' is an unique product which soothes and rejuvenates the tired eyes, due to their continuous exposure to dust, TV /computer screen, air conditioning and other modem lifestyle disorders. Bangalore market is choosen for the launch of Eye Spa as majority of its population are exposed to the above said lifestyle disorders. The company plans to roll out its products in other south Indian markets shortly, before their PAN India launch.

Bal Pharma Limited, Annual General Meeting, Sep 22, 2015

Bal Pharma Limited, Annual General Meeting, Sep 22, 2015., at 11:30 Indian Standard Time.

Bal Pharma Limited Appoints Sanjay Kumar Agarwal as Company Secretary, Compliance Officer, Deputy General Manager-Finance and CFO

Bal Pharma Limited announced at its board meeting held on August 13, 2015, the board approved the appointment of Mr. Sanjay Kumar Agarwal as company secretary and compliance officer of the company. He is also designated as deputy general manager-finance & CFO of the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLP:IN 75.35 INR 0.00

BLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLP.
View Industry Companies

Industry Analysis


Industry Average

Valuation BLP Industry Range
Price/Earnings 33.0x
Price/Sales 0.5x
Price/Book 1.7x
Price/Cash Flow 9.1x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAL PHARMA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at